Cefaloglycin

Cefaloglycin is a cephalosporin antibiotic used in the treatment of various bacterial infections. It belongs to the first generation of cephalosporins and is known for its effectiveness against Gram-positive bacteria.

Chemical structure

Cefaloglycin is characterized by its beta-lactam ring, which is crucial for its antibacterial activity. The presence of the beta-lactam ring allows cefaloglycin to inhibit bacterial cell wall synthesis, leading to cell lysis and death.

Mechanism of action

Cefaloglycin works by binding to penicillin-binding proteins (PBPs) located inside the bacterial cell wall. This binding inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. The inhibition of cell wall synthesis ultimately leads to bacterial cell death.

Pharmacokinetics

Cefaloglycin is administered orally and is absorbed from the gastrointestinal tract. It is distributed widely in body tissues and fluids. The drug is primarily excreted unchanged in the urine, making it effective for treating urinary tract infections.

Clinical uses

Cefaloglycin is used to treat a variety of infections caused by susceptible strains of bacteria. These include:

• Urinary tract infections
• Respiratory tract infections
• Skin and soft tissue infections

Side effects

Common side effects of cefaloglycin include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Allergic reactions, though rare, can occur and may manifest as rash, pruritus, or more severe reactions such as anaphylaxis.

Related pages

• Cephalosporin
• Antibiotic
• Beta-lactam antibiotic